Get the Stockscreener App
3.43
0.88%
0.03
After Hours:
3.49
0.06
+1.75%
Bionano Genomics Inc stock is traded at $3.43, with a volume of 68,147.
It is up +0.88% in the last 24 hours and up +3.31% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$3.40
Open:
$3.43
24h Volume:
68,147
Relative Volume:
0.67
Market Cap:
$11.54M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.1929
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
+0.88%
1M Performance:
+3.31%
6M Performance:
-70.44%
1Y Performance:
-90.72%
1-Day Range:
$3.40
$3.47
1-Week Range:
$3.31
$3.47
52-Week Range:
$2.68
$40.20
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.43 | 11.44M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
518.62 | 183.53B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.85 | 50.43B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.35 | 43.27B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
257.92 | 37.30B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.89 | 16.32B | 2.90B | 467.20M | 306.90M | 6.37 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
What analysts say about Bionano Genomics Inc. stockExceptional earning trajectories - Jammu Links News
What drives Bionano Genomics Inc. stock priceFree Stock Market Mentorship - Jammu Links News
Bionano Genomics Inc. Stock Analysis and ForecastExplosive returns - Jammu Links News
Optical Genome Mapping Market Size, Industry Growth Report - openPR.com
What makes Bionano Genomics Inc. stock price move sharplyPredictable High Return Trades - Newser
How Bionano Genomics Inc. stock performs during market volatilityReliable Low Risk Signals - Newser
Why Bionano Genomics Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Recommendation of “Hold” by Analysts - Defense World
(BNGO) Long Term Investment Analysis - news.stocktradersdaily.com
Bionano Genomics (NASDAQ:BNGO) Stock Price Up 0.9% – Time to Buy? - Defense World
21 Global Studies Validate Bionano Optical Genome Mapping at Major EU Genetics Conference | BNGO Stock News - Stock Titan
BioNano Genomics Enhances Governance with New Appointment - TipRanks
(BNGO) Investment Analysis and Advice - news.stocktradersdaily.com
410,469 Shares in Bionano Genomics, Inc. (NASDAQ:BNGO) Acquired by Jane Street Group LLC - Defense World
Northern Trust Corp Sells 11,004 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics stock rises on Q1 revenue beat - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Rating of “Hold” by Analysts - Defense World
Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Wall Street Zen - Defense World
Maxim Group Upgrades Bionano Genomics (NASDAQ:BNGO) to Buy - Defense World
Maxim Group Upgrades Bionano Genomics (BMV:BNGO) - Nasdaq
Maxim Group Upgrades Bionano Genomics (LSE:0A4K) - Nasdaq
Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upg - GuruFocus
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upgrade | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brighten | BNGO Stock News - GuruFocus
Maxim Upgrades Bionano Genomics to Buy From Hold, $8 Price Target - marketscreener.com
Bionano (BNGO) Achieves Milestone with New CPT Code for Genetic - GuruFocus
Bionano Laboratories Announces a Second Category I CPT Code - GlobeNewswire
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2025 Earnings Call Transcript - Insider Monkey
Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more - MSN
Biggest stock movers Thursday: CSCO, FL, BABA, BNGO, and more - MSN
Biggest stock movers Thursday: CSCO, BNGO, and more - MSN
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Genomics 2025 Q1 Earnings Strong Performance as Net Income Improves 90.1% - AInvest
Bionano Genomics Q1 2025 Earnings Call Transcript - MarketBeat
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 202 - GuruFocus
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall - Asianet Newsable
Bionano Genomics (BNGO) Refocuses Strategy Amid Revenue Dip - GuruFocus
Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin - MSN
Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):